Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Abrupt Increases in Ferritin Levels May Indicate a Malignant Process and Not Changes in Iron Overload in Thalassemic Patients

Polyxeni Delaporta, Elena Chatzikalil, Dimitra Kyriakopoulou, Sofirela Berdalli, Vasiliki Chouliara, Maria-Ioanna Hatzieleftheriou, Stavroula Mylona, Antonis Kattamis

Blood (2024) 144 (Supplement 1): 3860.

https://doi.org/10.1182/blood-2024-206111

Published: 2024

Journal Articles

Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study

Blood (2024) 144 (Supplement 1): 2703.

https://doi.org/10.1182/blood-2024-206661

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2024) 144 (Supplement 1): 512.

https://doi.org/10.1182/blood-2024-205779

Published: 2024

Journal Articles

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Blood (2024) 144 (Supplement 1): 409.

https://doi.org/10.1182/blood-2024-200867

Published: 2024

Journal Articles

Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Do Benefit from the Addition of Blinatumomab to Backbone Treatment Protocols

Georgia Avgerinou, Maria Fillipidou, Ilona Binenbaum, Stavros Glentis, Katerina Kaisari, Eugene Goussetis, Anna Komitopoulou, Foteini Perganti, Stefanos I. Papadhimitriou, Marianna Tzanoudaki, Antonis Kattamis

Blood (2024) 144 (Supplement 1): 5886.

https://doi.org/10.1182/blood-2024-206817

Published: 2024

Journal Articles

Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review

Janet L. Kwiatkowski, Sujit Sheth, Antonis Kattamis, Francesco Bianchi, Fernando Tricta, Caroline Fradette, Roberta Luzzi, Antonio Piga

Blood (2024) 144 (Supplement 1): 5268.

https://doi.org/10.1182/blood-2024-207562

Published: 2024

Journal Articles

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Blood (2024) 144 (15): 1633–1645.

https://doi.org/10.1182/blood.2023023349

Published: 2024

Includes: Supplemental data

Journal Articles

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2023) 142 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2023-190534

Published: 2023

Journal Articles

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Khaled M Musallam, Ali T Taher, Antonis Kattamis, Maria Domenica Cappellini, Jennifer Lord-Bessen, Mrudula Glassberg, Christopher Pelligra, Shien Guo, Loyse Felber Medlin, Luciana Moro Bueno, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2023-173366

Published: 2023

Journal Articles

Measurable Residual Disease As Assessed By Flow Cytometry As Predictor of Survival in Pediatric AML Patients

Georgia Avgerinou, Maria Fillipidou, Ilona Binenbaum, Mariana Tzanoudaki, Stefanos I. Papadhimitriou, Antonis Kattamis

Blood (2023) 142 (Supplement 1): 6017.

https://doi.org/10.1182/blood-2023-189335

Published: 2023

Journal Articles

A Novel Variant of the CYCS Gene Alters Apoptosis of Megakaryocytes in a Family with Thrombocytopenia

Konstantina Giavi, Stavros Glentis, Anthi Bouchla, Anastasia Apostolidou, Nikolaos M. Marinakis, Antonis Kattamis, Eleni Katsantoni, Vasiliki Pappa

Blood (2023) 142 (Supplement 1): 5409.

https://doi.org/10.1182/blood-2023-186060

Published: 2023

Journal Articles

Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial

Ali T Taher, Vip Viprakasit, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, John B. Porter, Thomas D Coates, Gian Luca Forni, Khaled M. Musallam, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Marta Reverte, Richard Wei, Luciana Moro Bueno, Maria Domenica Cappellini

Blood (2023) 142 (Supplement 1): 3847.

https://doi.org/10.1182/blood-2023-174097

Published: 2023

Journal Articles

Evolving Changes in the Characteristics of Death in Transfusion Dependent Thalassemia in Greece

Polyxeni Delaporta, Elena Chatzikalil, Vassilis Ladis, Maria Moraki, Antonis Kattamis

Blood (2023) 142 (Supplement 1): 1103.

https://doi.org/10.1182/blood-2023-188539

Published: 2023

Journal Articles

Lnp-Targeting Hematopoietic Stem Cells and Lentiviral Gene Transfer to Generate and Rescue a Novel Mouse Model of Lethal Alpha-Thalassemia

Maxwell Chappell, Laura Breda, Danuta Jadwiga Jarocha, Michael Triebwasser, Tyler E Papp, Valentina Ghiaccio, Megan T Fedorky, Amaliris Guerra, Kandace Gollomp, Osheiza Y. Abdulmalik, Nattiya Teawtrakul, Stavros Glentis, Antonis Kattamis, Hamideh Parhiz, Stefano Rivella

Blood (2022) 140 (Supplement 1): 300–302.

https://doi.org/10.1182/blood-2022-166621

Published: 2022

Journal Articles

Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent β-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis

Olivier Hermine, Maria Domenica Domenica Cappellini, Ali T. Taher, Thomas D. Coates, Vip Viprakasit, Antonis Kattamis, Jeevan K. Shetty, Marija Bosilkovska Weisskopf, Natalia Holot, Sadanand Vodala, Wen-Ling Kuo, John B. Porter

Blood (2022) 140 (Supplement 1): 8215–8217.

https://doi.org/10.1182/blood-2022-156985

Published: 2022

Journal Articles

High Incidence of Clonal Hematopoiesis in Transfusion-Dependent Thalassemia Patients

Elena E. Solomou, Polyxeni Delaporta, Laidou Stamatia, Efthymia-Vasilina Katsika, Marianna Chatzieleftheriou, Konstantina Toutoudaki, Stavros Glentis, Kostas Stamatopoulos, Anastasia Chatzidimitriou, Antonis Kattamis

Blood (2022) 140 (Supplement 1): 8213–8214.

https://doi.org/10.1182/blood-2022-159246

Published: 2022

Journal Articles

Erythroid Response in Patients with Non-Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Long-Term Data from the BEYOND Trial

Ali T. Taher, Vip Viprakasit, Maria Domenica Domenica Cappellini, Antonio Piga, John B. Porter, Thomas D. Coates, Khaled M. Musallam, Gian Luca Forni, Jeevan K. Shetty, Marija Bosilkovska Weisskopf, Richard Wei, Wen-Ling Kuo, Antonis Kattamis

Blood (2022) 140 (Supplement 1): 8210–8212.

https://doi.org/10.1182/blood-2022-157512

Published: 2022

Journal Articles

Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia

Blood (2022) 140 (Supplement 1): 8205–8207.

https://doi.org/10.1182/blood-2022-167675

Published: 2022

Journal Articles

Effect of Luspatercept in β-Thalassemia Patients with β0/β0 Genotype: A Subgroup Analysis of the BELIEVE Study

Sujit Sheth, Olivier Hermine, Ali T. Taher, Kevin H.M. Kuo, John B. Porter, Antonio Piga, Thomas D. Coates, Antonis Kattamis, Loyse Felber Medlin, Wen-Ling Kuo, Natalia Holot, Maria Domenica Domenica Cappellini

Blood (2022) 140 (Supplement 1): 1946–1948.

https://doi.org/10.1182/blood-2022-157511

Published: 2022

Journal Articles

I-FISH Guided Cytogenetic Study of Non-Hodgkin Lymphomas in Children and Adolescents: Correlation with Etiology and Outcome

Georgia Avgerinou, Maria Filippidou, Ilona Binenbaum, Tatiana-Soultana Tziola, Kalliopi Stefanaki, Katerina Katsibardi, Dimitrios Pavlidis, Antonis Kattamis, Sophia Polychronopoulou, Marina Mantzourani, Stefanos I Papadhimitriou

Blood (2022) 140 (Supplement 1): 11901–11902.

https://doi.org/10.1182/blood-2022-165198

Published: 2022

NARROW

Abrupt Increases in Ferritin Levels May Indicate a Malignant Process and Not Changes in Iron Overload in Thalassemic Patients

Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Do Benefit from the Addition of Blinatumomab to Backbone Treatment Protocols

Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Measurable Residual Disease As Assessed By Flow Cytometry As Predictor of Survival in Pediatric AML Patients

A Novel Variant of the CYCS Gene Alters Apoptosis of Megakaryocytes in a Family with Thrombocytopenia

Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial

Evolving Changes in the Characteristics of Death in Transfusion Dependent Thalassemia in Greece

Lnp-Targeting Hematopoietic Stem Cells and Lentiviral Gene Transfer to Generate and Rescue a Novel Mouse Model of Lethal Alpha-Thalassemia

Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent β-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis

High Incidence of Clonal Hematopoiesis in Transfusion-Dependent Thalassemia Patients

Erythroid Response in Patients with Non-Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Long-Term Data from the BEYOND Trial

Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia

Effect of Luspatercept in β-Thalassemia Patients with β0/β0 Genotype: A Subgroup Analysis of the BELIEVE Study

I-FISH Guided Cytogenetic Study of Non-Hodgkin Lymphomas in Children and Adolescents: Correlation with Etiology and Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only